Top 10 Alzheimer’s Disease Stories of 2017

Top 10 Alzheimer’s Disease Stories of 2017
With 2017 behind us, Alzheimer's News Today looks forward to bringing our readers news and updates on Alzheimer’s disease research discoveries, treatment developments, clinical trials, and events in the year ahead. But as a reminder of all the great work being done to find treatments and improve the lives of those with Alzheimer’s, we will start the year by summing up the top 10 most-read stories of 2017. No. 10 — Florida Symposium to Address Medical Marijuana's Potential to Treat Alzheimer’s, Chronic Pain A conference on the use of medical marijuana in Alzheimer's disease in Florida attracted the attention of many of our readers. The symposium gathered medical professionals and focused on both medical and legal aspects of the use of cannabis-derived substances for the treatment of Alzheimer's patients. Some researchers believe that such substances may improve dementia symptoms and slow or prevent disease progression. No. 9 — Two Therapies, One Approved, Prevent Dementia-related Brain Damage in Mice This study reported that two drugs — Desyrel (trazodone hydrochloride), which is approved for depression, anxiety, and insomnia, and dibenzoylmethane (DBM), which is being tested in clinical trials for cancer — prevented brain tissue loss in mice. Since the medications have already been found safe in humans, researchers hope to soon test the drugs in Alzheimer’s patients. No. 8 — Bilingualism Appears to Protect the Brain from Alzheimer's Symptoms, Study Says Speaking two languages seems to protect the brain from the ravaging effects of Alzheimer’s disease, this study found. Alzheimer’s patients who spoke two languages had significantly better memories than their single-language speaking peers, despite being older and having poorer br
Subscribe or to access all post and page content.